Header Logo

Connection

SHANNON RONCA to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications SHANNON RONCA has written about Clinical Trials, Phase II as Topic.
SHANNON RONCA
Connection Strength
0.048
Clinical Trials, Phase II as Topic
  1. Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. 2022 02 23; 40(9):1253-1260.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.